コンテンツへスキップ
Merck

Choanal atresia associated with prenatal methimazole exposure: three new patients.

American journal of medical genetics. Part A (2004-07-22)
P Barbero, C Ricagni, G Mercado, R Bronberg, M Torrado
要旨

We report three patients with bilateral choanal atresia in children prenatally exposed to methimazole (MMI) in order to define a MMI embryopathy clinical pattern. The combination of choanal atresia and other specific malformations strongly resembles previously reported patients exposed to MMI in utero. At present, propylthiouracil is considered the best treatment in pregnancies. However in Argentina and some other countries MMI is the only antithyroid drug, possibly posing a significant risk to the unborn fetus.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
2-メルカプト-1-メチルイミダゾール, ≥99%
Supelco
メチマゾール, analytical standard
USP
メチマゾール, United States Pharmacopeia (USP) Reference Standard
Supelco
メチマゾール, VETRANAL®, analytical standard
メチマゾール, European Pharmacopoeia (EP) Reference Standard